Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein.
Kitsis
Richard N
RN
Department of Medicine, Cardiovascular Research Center, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Jialal
Ishwarlal
I
D000818:Animals; D002097:C-Reactive Protein / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003167:Complement Activation / Q000187:drug effects; D006586:Hexanes / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats
C510236:1,6-bis(phosphocholine)-hexane; D006586:Hexanes; D010767:Phosphorylcholine; D002097:C-Reactive Protein